Accéder au contenu
Merck

p38 regulates the tumor suppressor PDCD4 via the TSC-mTORC1 pathway.

Cell stress (2021-12-18)
Clarissa Braun, Karl Katholnig, Christopher Kaltenecker, Monika Linke, Nyamdelger Sukhbaatar, Markus Hengstschläger, Thomas Weichhart
RÉSUMÉ

Programmed cell death protein 4 (PDCD4) exerts critical functions as tumor suppressor and in immune cells to regulate inflammatory processes. The phosphoinositide 3-kinase (PI3K) promotes degradation of PDCD4 via mammalian target of rapamycin complex 1 (mTORC1). However, additional pathways that may regulate PDCD4 expression are largely ill-defined. In this study, we have found that activation of the mitogen-activated protein kinase p38 promoted degradation of PDCD4 in macrophages and fibroblasts. Mechanistically, we identified a pathway from p38 and its substrate MAP kinase-activated protein kinase 2 (MK2) to the tuberous sclerosis complex (TSC) to regulate mTORC1-dependent degradation of PDCD4. Moreover, we provide evidence that TSC1 and TSC2 regulate PDCD4 expression via an additional mechanism independent of mTORC1. These novel data extend our knowledge of how PDCD4 expression is regulated by stress- and nutrient-sensing pathways.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Rapamycin, InSolution, ≥98%, 5 mM, inhibits mTOR and blocks activation of p70 S6 Kinase
Sigma-Aldrich
Z-Leu-Leu-Leu-al, InSolution, ≥98%, 10 mM, reversible proteasome inhibitor